Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Fuentes

Showing results (131-140 of 148) with videos related to

Pageof 15
Sort By:
Journal of Medicinal Chemistry|June 25, 2005
1-Acyl-1H-[1,2,4]triazole-3,5-diamine analogues as novel and potent anticancer cyclin-dependent kinase inhibitors: synthesis and evaluation of biological activitiesRonghui Lin, Peter J Connolly, Shenlin Huang, et al.
Bioorganic & Medicinal Chemistry Letters|March 17, 2009
Synthesis and evaluation of 2,7-diamino-thiazolo[4,5-d] pyrimidine analogues as anti-tumor epidermal growth factor receptor (EGFR) tyrosine kinase inhibitorsRonghui Lin, Sigmond G Johnson, Peter J Connolly, et al.
Bioorganic & Medicinal Chemistry Letters|May 29, 2007
Synthesis and evaluation of pyrazolo[3,4-b]pyridine CDK1 inhibitors as anti-tumor agentsRonghui Lin, Peter J Connolly, Yanhua Lu, et al.
Lupus|September 23, 2015
Antiphospholipid antibody-mediated effects in an arterial model of thrombosis are dependent on Toll-like receptor 4P Laplante, R Fuentes, D Salem, et al.
Cirugia Pediatrica : Organo Oficial De La Sociedad Espanola De Cirugia Pediatrica|January 24, 2007
[Clinical management of terrorist bomb explosions]A Cañizo, A Parente, J A Navascués, et al.
Journal of Healthcare Quality Research|November 3, 2023
[12 months, 12 do not do. Patient safety campaign]C Ruiz-Huerta García de Viedma, M V Canto, C Cavero Esponera, et al.
Bioorganic & Medicinal Chemistry Letters|July 26, 2008
4-Amino-6-arylamino-pyrimidine-5-carbaldehyde hydrazones as potent ErbB-2/EGFR dual kinase inhibitorsGuozhang Xu, Marta C Abad, Peter J Connolly, et al.
Bioorganic & Medicinal Chemistry Letters|April 20, 2005
3-Acyl-2,6-diaminopyridines as cyclin-dependent kinase inhibitors: synthesis and biological evaluationRonghui Lin, Yanhua Lu, Steven K Wetter, et al.
Bioorganic & Medicinal Chemistry Letters|May 8, 2007
4-Aryl-5-cyano-2-aminopyrimidines as VEGF-R2 inhibitors: synthesis and biological evaluationTerry V Hughes, Stuart L Emanuel, Amanda K Beck, et al.
Nature|August 15, 2014
Inappropriate p53 activation during development induces features of CHARGE syndromeJeanine L Van Nostrand, Colleen A Brady, Heiyoun Jung, et al.
Pageof 15

Showing results (131-140 of 148) with videos related to

Sort By:
Pageof 15
Journal of Medicinal Chemistry|June 25, 2005
1-Acyl-1H-[1,2,4]triazole-3,5-diamine analogues as novel and potent anticancer cyclin-dependent kinase inhibitors: synthesis and evaluation of biological activitiesRonghui Lin, Peter J Connolly, Shenlin Huang, et al.
Bioorganic & Medicinal Chemistry Letters|March 17, 2009
Synthesis and evaluation of 2,7-diamino-thiazolo[4,5-d] pyrimidine analogues as anti-tumor epidermal growth factor receptor (EGFR) tyrosine kinase inhibitorsRonghui Lin, Sigmond G Johnson, Peter J Connolly, et al.
Bioorganic & Medicinal Chemistry Letters|May 29, 2007
Synthesis and evaluation of pyrazolo[3,4-b]pyridine CDK1 inhibitors as anti-tumor agentsRonghui Lin, Peter J Connolly, Yanhua Lu, et al.
Lupus|September 23, 2015
Antiphospholipid antibody-mediated effects in an arterial model of thrombosis are dependent on Toll-like receptor 4P Laplante, R Fuentes, D Salem, et al.
Cirugia Pediatrica : Organo Oficial De La Sociedad Espanola De Cirugia Pediatrica|January 24, 2007
[Clinical management of terrorist bomb explosions]A Cañizo, A Parente, J A Navascués, et al.
Journal of Healthcare Quality Research|November 3, 2023
[12 months, 12 do not do. Patient safety campaign]C Ruiz-Huerta García de Viedma, M V Canto, C Cavero Esponera, et al.
Bioorganic & Medicinal Chemistry Letters|July 26, 2008
4-Amino-6-arylamino-pyrimidine-5-carbaldehyde hydrazones as potent ErbB-2/EGFR dual kinase inhibitorsGuozhang Xu, Marta C Abad, Peter J Connolly, et al.
Bioorganic & Medicinal Chemistry Letters|April 20, 2005
3-Acyl-2,6-diaminopyridines as cyclin-dependent kinase inhibitors: synthesis and biological evaluationRonghui Lin, Yanhua Lu, Steven K Wetter, et al.
Bioorganic & Medicinal Chemistry Letters|May 8, 2007
4-Aryl-5-cyano-2-aminopyrimidines as VEGF-R2 inhibitors: synthesis and biological evaluationTerry V Hughes, Stuart L Emanuel, Amanda K Beck, et al.
Nature|August 15, 2014
Inappropriate p53 activation during development induces features of CHARGE syndromeJeanine L Van Nostrand, Colleen A Brady, Heiyoun Jung, et al.
Pageof 15